Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-09-30
2008-10-14
Dentz, Bernard (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S334000, C514S336000, C514S344000, C514S352000, C546S257000, C546S258000, C546S281400, C546S289000, C546S307000, C546S308000, C546S309000, C546S310000, C546S311000
Reexamination Certificate
active
07435743
ABSTRACT:
Pyrimidine compounds of general formula:wherein —R1representsin which R11is hydrogen, C1-6alkyl, halogen, hydroxy, C1-12alkoxy, nitro, amino, C1-6alkylsulfonylamino, C1-6alkoxycarbonyl, C1-6alkylamino, di (C1-6alkyl)amino, C1-6alkanoylamino, phenyl C1-6alkylamino, phenylsulfonylamino, or —O—(CH2)n—R111; R2represents hydrogen or halogen; R3represents hydrogen, —CR31R32R33; R4is hydrogen, carbamoyl, CN, carboxyl, etc.; R5is amino, C1-6alkylamino, di C1-6alkylamino, etc. or salt thereof. The compound has an excellent anti-inflammatory activity, and other biological activity.
REFERENCES:
patent: 4003908 (1977-01-01), Denzel et al.
patent: WO 01/27103 (2001-04-01), None
Nagai, W., et al., “Structures and Fluorescence of Secondary Products Produced from the Cope-Knoevenagel Reaction of 2-Phenylpropionaldehyde with Methyl Cyanoacetate”, J. Heterocyclic Chem., 33: 123-128 (1996).
Sakurai, A., et al., “The Cyclization of Ethyl Cyanoacetate and Salicylaldehyde or 3- Methoxysalicylaldehyde with Ketones by Means of Ammonium Acetate”, Bull. Chem. Soc. Japan, 43: 2925-2933 (1970).
Manna, F., et al., “Anti-inflammatory, Analgesic and Antipyretic 4,6-disubstituted 3-cyano-2-aminopyridines”, Eur. J. Med. Chem., 34: 245-254 (1999).
Chem. Abstr. 92: 163866, Takeuchi, I. et al., “Syntheses of Nitrogen-containing Heterocyclic Compounds. XXXVII. On the Antimicrobial Activity and Synthesis of 2-phenylquinoline 1-oxides and phenyl-1, 8-naphthyridines”, Yakugaku Zasshi, 99: 451-457 (1979).
Manna, F., et al., “Anti-inflammatory, Analgesic and Antipyretic 4, 6-disubstituted 3-cyanopyridine-2-ones and 3-cyano-2-aminopyridines”, Eur. J. Med. Chem., 27: 627-632 (1992).
Chem. Abstr. 134: 222965, Singh, G., et al., “Synthesis of Some Novel 4-imino-3, 5, 7-trisubstituted Pyrido[2, 3- d]pyrimidine-2(1H)-thiones and Their Nucleosides as Potential Therapeutic Agents”, Phosphorus, Sulfur, and Silicon, 165: 107-116 (2000).
Chem. Abstr. 126: 89234, Desai, J., et al., “Synthesis and Biological Studies of Some 2-amino-3-cyano-4-aryl-6-(2′-hydroxy-3′bromo/3′-nitro-5-′methylphenyl) Pryidines”, Oriental J. Chem., 12: 209-210 (1996).
Singh, B., et al., “Novel cAMP PDE III Inhibitors: Imidazo [4,5-b]pyridin-2(3H)-ones and Thiazolo [4,5-b]pyridin-2(3H)-ones and Their Analogs”, J. Med. Chem., 37: 248-254 (1994).
Fuchikami Kinji
Kadono Hiroshi
Komura Hiroshi
Koriyama Yuji
Lowinger Timothy B.
Bayer Aktiengesellschaft
Dentz Bernard
Edwards Angell Palmer & & Dodge LLP
Kramer Barry
Loren Ralph A.
LandOfFree
Pyridine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyridine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyridine derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3998279